• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异基因造血干细胞移植后霍奇金淋巴瘤:罕见事件的罕见表现。

Postallogeneic stem cell transplant Hodgkin lymphoma: Rare presentation of an uncommon occurrence.

作者信息

Iftikhar Raheel, Un Nisa Chaudhry Qamar, Satti Tariq Mehmood, Kamran Mahmood Syed, Ghafoor Tariq

机构信息

Armed forces Bone marrow transplant centre Rawalpindi Pakistan.

出版信息

Clin Case Rep. 2019 Jun 18;7(7):1442-1444. doi: 10.1002/ccr3.2095. eCollection 2019 Jul.

DOI:10.1002/ccr3.2095
PMID:31360508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6637351/
Abstract

Post-transplant lymphoproliferative disorders are rare but potentially life-threatening complication of HSCT. Although not frequently reported but PTLD can occur as a late post-transplant complication in HSCT recipients. A high index of suspicion should be kept for early diagnosis of these disorders as delay in diagnosis can have catastrophic implications.

摘要

移植后淋巴细胞增殖性疾病是异基因造血干细胞移植罕见但可能危及生命的并发症。尽管报道不频繁,但PTLD可作为异基因造血干细胞移植受者移植后的晚期并发症出现。对于这些疾病的早期诊断应保持高度怀疑,因为诊断延迟可能会产生灾难性后果。

相似文献

1
Postallogeneic stem cell transplant Hodgkin lymphoma: Rare presentation of an uncommon occurrence.异基因造血干细胞移植后霍奇金淋巴瘤:罕见事件的罕见表现。
Clin Case Rep. 2019 Jun 18;7(7):1442-1444. doi: 10.1002/ccr3.2095. eCollection 2019 Jul.
2
Late Epstein-Barr virus-related post-transplant lymphoproliferative disorder with intestinal involvement in patient with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后慢性移植物抗宿主病患者中晚期爱泼斯坦-巴尔病毒相关移植后淋巴细胞增生性疾病伴肠道受累
Cent Eur J Immunol. 2020;45(2):233-236. doi: 10.5114/ceji.2020.96930. Epub 2020 Jul 27.
3
Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report.EB 病毒阳性淋巴组织增生性疾病在急性髓系白血病患者中表现为肺部疾病:病例报告。
J Med Case Rep. 2021 Mar 28;15(1):170. doi: 10.1186/s13256-021-02744-2.
4
Primary cutaneous Hodgkin-like polymorphic post-transplant lymphoproliferative disorder.
J Cutan Pathol. 2019 May;46(5):358-362. doi: 10.1111/cup.13427. Epub 2019 Feb 27.
5
Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.实体器官移植受者中与 Epstein-Barr 病毒相关的移植后淋巴组织增生性疾病。
Clin Microbiol Infect. 2014 Sep;20 Suppl 7:109-18. doi: 10.1111/1469-0691.12534.
6
Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development.造血干细胞移植后爱泼斯坦-巴尔病毒相关移植后淋巴细胞增殖性疾病的早期诊断与治疗:一种正在发展的方法。
Bone Marrow Transplant. 2006 Mar;37(6):539-46. doi: 10.1038/sj.bmt.1705289.
7
Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment.儿童异基因造血干细胞移植中与爱泼斯坦-巴尔病毒相关的移植后淋巴细胞增生性疾病前瞻性预防方案:病毒学监测及一线治疗
Transpl Infect Dis. 2016 Feb;18(1):44-54. doi: 10.1111/tid.12485. Epub 2016 Jan 30.
8
Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.实体器官和造血干细胞移植后的移植后淋巴组织增生性疾病。
Leuk Lymphoma. 2019 Jan;60(1):142-150. doi: 10.1080/10428194.2018.1474462. Epub 2018 Jul 3.
9
T-cell lymphoma with a granulomatous lesion of the lungs after autologous hematopoietic stem cell transplantation for Epstein-Barr virus-positive diffuse large B-cell lymphoma: a unique rare case of metachronous B-cell and T-cell lymphoma.自体造血干细胞移植治疗 EBV 阳性弥漫性大 B 细胞淋巴瘤后肺部伴有肉芽肿病变的 T 细胞淋巴瘤:B 细胞和 T 细胞淋巴瘤异时性发生的独特罕见病例。
Diagn Pathol. 2020 Oct 9;15(1):125. doi: 10.1186/s13000-020-01038-3.
10
A Rare Case of Classical Hodgkin Lymphoma Diagnosed 10 Years after Liver Transplant.肝移植10年后诊断出经典型霍奇金淋巴瘤的罕见病例。
Case Rep Oncol. 2017 Oct 17;10(3):923-927. doi: 10.1159/000481452. eCollection 2017 Sep-Dec.

引用本文的文献

1
Successful low-dose chemotherapy for refractory Epstein-Barr virus-related post-transplant lymphoproliferative disorder following hematopoietic stem cell transplantation in a child with Wiskott-Aldrich syndrome.成功运用低剂量化疗治疗患有维斯科特-奥尔德里奇综合征的儿童造血干细胞移植后难治性爱泼斯坦-巴尔病毒相关移植后淋巴细胞增殖性疾病
Clin Case Rep. 2021 May 24;9(5):e04111. doi: 10.1002/ccr3.4111. eCollection 2021 May.

本文引用的文献

1
Epstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature Review.抗胸腺细胞球蛋白治疗再生障碍性贫血后并发脑炎的爱泼斯坦-巴尔病毒相关淋巴增殖性疾病经利妥昔单抗治疗后缓解:一例报告及文献综述
Intern Med. 2017;56(6):701-706. doi: 10.2169/internalmedicine.56.7722. Epub 2017 Mar 17.
2
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines.异基因造血干细胞移植后患者的爱泼斯坦-巴尔病毒感染及移植后淋巴增殖性疾病的管理:第六届欧洲白血病感染会议(ECIL-6)指南
Haematologica. 2016 Jul;101(7):803-11. doi: 10.3324/haematol.2016.144428.
3
Infectious Mononucleosis.传染性单核细胞增多症
Curr Top Microbiol Immunol. 2015;390(Pt 1):211-40. doi: 10.1007/978-3-319-22822-8_9.
4
Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab.在抢先使用利妥昔单抗时代,高危异基因造血干细胞移植后爱泼斯坦-巴尔病毒相关并发症的影响
Bone Marrow Transplant. 2015 Apr;50(4):579-84. doi: 10.1038/bmt.2014.298. Epub 2015 Jan 12.
5
EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era.体内T细胞去除的同种异体移植后EB病毒相关移植后淋巴细胞增殖性疾病:利妥昔单抗时代的临床特征、病毒载量相关性及预后因素
Bone Marrow Transplant. 2014 Feb;49(2):280-6. doi: 10.1038/bmt.2013.170. Epub 2013 Nov 11.
6
Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.儿童和成人造血干细胞移植后 EBV 相关淋巴组织增生性疾病对利妥昔单抗治疗的反应及危险因素分析:来自欧洲血液和骨髓移植学会传染病工作组的研究。
Clin Infect Dis. 2013 Sep;57(6):794-802. doi: 10.1093/cid/cit391. Epub 2013 Jun 13.
7
Reduced PTLD-related mortality in patients experiencing EBV infection following allo-SCT after the introduction of a protocol incorporating pre-emptive rituximab.在引入包含抢先使用利妥昔单抗的方案后,异基因造血干细胞移植后发生EBV感染的患者中,与移植后淋巴细胞增殖性疾病(PTLD)相关的死亡率降低。
Bone Marrow Transplant. 2013 Nov;48(11):1465-71. doi: 10.1038/bmt.2013.84. Epub 2013 Jun 10.
8
Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab.接受抢先使用利妥昔单抗治疗的异基因干细胞移植高危受者中,EB病毒血症的预后因素及结局
Transpl Infect Dis. 2013 Jun;15(3):259-67. doi: 10.1111/tid.12061. Epub 2013 Feb 13.